Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21.1Revenue $M0.0Net Margin (%)-72,738.1Z-Score-6.6
Enterprise Value $M17.0EPS $-3.1Operating Margin %-69,666.7F-Score3
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-72,738.1Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %-29.3Quick Ratio2.1Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %5.7Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-83.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-96.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M12.0ROI % (ttm)-120.6Gross Margin Increase y-yN

Gurus Latest Trades with ECTE

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ECTE is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ECTE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nordlicht Mark10% Owner 2014-06-30Buy65,739$2.2-20 view
Nordlicht Mark10% Owner 2014-06-26Buy17,300$2.2-20 view
Nordlicht Mark10% Owner 2014-06-24Buy16,961$2.2-20 view
Nordlicht Mark10% Owner 2013-12-10Buy69,569$2.75-36 view
Doman Robert FDirector 2013-03-22Buy15,000$0.8120 view
GRIECO WILLIAMDirector 2013-03-21Buy30,000$0.76131.58 view
SMITH JAMES FRANCISDirector 2012-08-23Buy20,000$1.4719.73 view

Press Releases about ECTE :

    Quarterly/Annual Reports about ECTE:

    News about ECTE:

    Articles On GuruFocus.com
    5 Healthcare Picks for 2012 Mar 21 2012 

    More From Other Websites
    2:18 am Echo Therapeutics' largest stockholder accuses Board of impeding the rights of Stockholders Sep 15 2014
    Echo Therapeutics Board Once Again Impedes The Rights Of Echo Stockholders Sep 12 2014
    IRadimed (IRMD) Jumps: Stock Moves 7.4% Higher Sep 05 2014
    The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and... Sep 03 2014
    ECHO THERAPEUTICS, INC. Financials Aug 22 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Costs... Aug 19 2014
    Echo Therapeutics Sees Narrower Loss but Lags Estimates Aug 18 2014
    Echo Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Provides Business Update Aug 14 2014
    ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Aug 14 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jul 29 2014
    Platinum Delivers Letter To Echo Therapeutics, Inc. Demanding To Inspect Certain Books And Records... Jul 23 2014
    Platinum Reports On Town Hall Meeting For Echo Therapeutics, Inc. Stockholders Jul 22 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jul 16 2014
    Disturbing Self-Dealing By Repudiated Echo Directors Forces Platinum To Exercise Contractual Right... Jul 10 2014
    US companies adopt bylaws that could quash some investor lawsuits Jul 07 2014
    Two Companies Say Yes to New 'Loser Pays' Option Jul 03 2014
    Echo Therapeutics appoints Kimberly Burke as interim CEO Jul 02 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 02 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Change in... Jun 27 2014
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jun 25 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK